ABSTRACT: Investigation of a DCM extract of the bark of Pleiogynium timoriense from the former Merck collection of natural product extracts for antiproliferative activity indicated that it was active with an IC 50 value of 1.3 μg/mL against the A2780 ovarian cancer cell line. Bioassay-directed fractionation of this extract yielded the three new bioactive trihydroxyalkylcyclohexenones 1−3. Their structures were determined by a combination of spectroscopic and chemical methods. Compounds 1−3 exhibited submicromolar antiproliferative activity against the A2780 human ovarian cancer cell line, with IC 50 values of 0.8, 0.7, and 0.8 μM, respectively.
A s part of an investigation of the former Merck natural products extract library for antiproliferative constituents, now maintained by the Natural Products Discovery Institute, 1 we identified a DCM fraction of the ethanol extract of the bark of Pleiogynium timoriense (Anacardiaceae) as a promising extract with an IC 50 value of 1.3 μg/mL against the A2780 ovarian cancer cell line. P. timoriense, also known as the Burdekin plum, is a tree found in northeast Australia and Malaysia as well as locations in the south-central Pacific and southwestern Pacific. 2 Its fruit is used to make jam, 3 and its leaves have been reported to be a source of antioxidants. Twelve compounds, including kaempferol, gallic acid, various kaempferol, quercitin, and myricetin glycosides, and three galloyl derivatives, have been identified from the ethanolic extract of the leaves. 4 It has also been reported that cyanidin 3-glucoside can be found in the fruit of P. timoriense. 5, 6 This DCM fraction was selected for fractionation based on its antiproliferative activity and the lack of reported antiproliferative compounds from the species.
The DCM fraction (0.30 g) was fractionated using Sephadex LH-20 column chromatography and two rounds of C 18 HPLC to yield the three active compounds 1−3. Compound 2 was obtained in the largest amount and was investigated first. 13 C NMR spectrum (C-1, δ 200.2; C-2, δ 126.4; C-3, δ 145.9). A large peak for methylene protons in the 1 H NMR spectrum (δ 1.22− 1.34) as well as a triplet at δ 0.88 (H-19′, 3H, J = 6.9 Hz) indicated the presence of a long alkyl chain in 2. This was consistent with the 13 C NMR data, which showed 10 signals at approximately δ 29 as well as signals at δ 23.0 (C-2′), 22.7 (C-18′), and 14.7 (C-19′). The NMR spectroscopic data are comparable to those of other known trihydroxyalkylcyclohexenone derviatives. 7−10 The presence of a double bond within the alkyl chain was indicated by a signal at δ 5.34 (2H, m) in the 1 H NMR spectrum as well as by COSY correlations from δ 5.34 (H-10′, H-11′) to δ 2.00 (H-9′, H-12′).
COSY correlations between H-3 and H-4 as well as H-4 and H-5 were used to establish the positions of C-4 and C-5 ( Figure  1 ). The lack of other correlations in the COSY spectra indicated that C-5 must be attached to an oxygenated tertiary carbon (C-6). HMBC correlations of H-2 to C-6, H-4 to C-6, and H-5 to C-1 (Figure 1 ) indicated that the structure contained a cyclic moiety, which is consistent with the calculated hydrogen deficiency index of four.
The configuration of the double bond in the alkyl chain was assigned as Z based on the shifts of the adjacent carbon atoms (δ 27.2 C-9′ and C-12′), which would have been more shielded in the case of an E-configuration (δ ∼32). 11, 12 The connectivity of the alkyl chain at C-6 was determined from the HMBC spectrum, which showed long-range correlations from H-1′ to C-6. The remaining 13 C NMR signals were assigned using HSQC and HMBC spectroscopy. Complete NMR assignments of all carbons and protons for 2 are reported in Table 1 . The location of the double bond in the alkenyl chain was determined through MS analysis of the products resulting from derivatization with dimethyl disulfide, following the method of Mansour 13 and Roumy. 7, 8, 10 However, the observed coupling constants of H-2 and H-3 in its 1 H NMR spectrum (H-2, dd, J = 1.1, 10.2 Hz; H-3, ddd, J = 1.1, 3.7, 10.2 Hz) are consistent with those of similar alkylcyclohexenones with the same relative configuration as proposed.
14 In order to further support our proposed relative configuration, the cyclic double bond of 2 was selectively reduced with diphenylsilane in the presence of ZnCl 2 and Pd(PPh 3 ) 4 to give the substituted cyclohexanone 4.
Irradiation of H-3 in a selective NOE experiment indicated correlations to H-1′ and H-4, but no correlation was observed to H-5b (δ 1.84), which indicated that H-3 was equatorial (Figure 2) . The small coupling constants observed for H-3 in the 1 H NMR spectrum of 4 (1H, dd, J = 4.5, 1.1 Hz) allowed the assignment of an equatorial orientation for H-4 in 4 and, thus, the corresponding pseudoequatorial orientation of H-4 in 2. A correlation was observed from H-1′ (δ 1.7) to H-6a (δ 2.7) in a 2D NOESY spectrum, indicating that the alkyl chain was in an axial orientation. The conformational preference for three axial substituents and only one equatorial substituent in 4 is presumably due to hydrogen bond formation between the carbonyl and the C-2 hydroxy groups.
The absolute configuration of 1 was determined by application of the dibenzoate chirality rule. The three isolated compounds are similar in structure to other known hydroxyalkylcyclohexenones that are found from Tapirira obtusa, T. guianesnsis, and Lannea edulis in the family Anacardiaceae. 9, 11, 17 Furthermore, they contain the same oxygenation pattern as the zeylenones, many of which have been isolated from various members of the Uvaria genus (Annonaceae). 18−20 The antiproliferative activities of the three new compounds were determined against the A2780 ovarian cancer cell line. All three compounds exhibited moderate antiproliferative activity, with IC 50 values of 0.8 ± 0.4, 0.7 ± 0.3, and 0.8 ± 0.5 μM, respectively.
■ EXPERIMENTAL SECTION
General Experimental Procedures. Optical rotations were recorded on a JASCO P-2000 polarimeter, and UV spectra were measured on a Shimadzu UV-1201 spectrophotometer. ECD analysis was performed on a JASCO J-810 spectropolarimeter with a 0.1 cm cell in MeOH at room temperature under the following conditions: speed 50 nm/min, time constant 1 s, bandwidth 2.0 nm. 1 H and 13 C NMR spectra were recorded using either Bruker Avance 500 or 600 spectrometers. Mass spectra were obtained on an Agilent 6220 LC-TOF-MS or a Thermo Electron TSQ LC-ESI-MS. Semipreparative HPLC was performed using Shimadzu LC-10AT pumps coupled with a Shimadzu SPD M10A diode array detector, a SCL-10A system controller, and a Cogent Bidentate C 18 column (250 × 10 mm) or a Varian Lichrosorb 5 Diol column (250 × 10 mm).
Antiproliferative Bioassay. The assay was performed at Virginia Tech according to specifications previously described. 21 The A2780 cell line is a drug-sensitive ovarian cancer cell line. 22 Plant Material. Bark of Pleiogynium timoriense (DC) Leenh. was collected by Dr. Paul Cox under the auspices of the New York Botanical Garden (NYBG) from a seaward-facing forest on the island of Eua, Tonga, in July 1987; a voucher specimen, PC01113 (ID number 40077), is on deposit at the NYBG.
Extraction and Isolation. An EtOH extract of the bark of P. timoriense was subjected to liquid−liquid partitioning to give active hexanes, DCM, and aqueous MeOH fractions with IC 50 values against the A2780 ovarian cancer cell line of 3.0, 1.3, and 6.2 μg/mL, respectively. The active DCM fraction 23050-C6 (0.30 g) was fractionated using Sephadex LH-20 column chromatography (1:1 DCM/MeOH) to generate an active fraction (222 mg, IC 50 0.5 μg/ mL). This fraction was further purified utilizing C 18 HPLC (MeOH/ H 2 O gradient) to yield three semipure active fractions. These fractions were further purified using C 18 HPLC (MeCN/H 2 O gradient) to yield the active compounds 1 (5.4 mg), 2 (6.9 mg), and 3 (1.4 mg). C and 2D NMR spectra of compounds 1−3, 1 H NMR spectra of 4 and 5, COSY, NOESY, selective TOCSY, and NOE spectra of 4, and ECD spectra of 1 and 5. The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/acs.jnatprod.5b00119.
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